• Mon, January 28, 2019
  • Wed, January 23, 2019
  • Thu, January 24, 2019
  • Fri, January 25, 2019

David Amsellem Upgraded (TEVA) to Hold and Increased Target to $16 on, Jan 23rd, 2019

David Amsellem of Piper Sandler, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $15 to $16 on, Jan 23rd, 2019.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Ami Fadia of "Leerink Swann" Upgraded from Sell to Hold on, Monday, October 1st, 2018


These are the ratings of the 3 analyists that currently disagree with David


  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
  • David Risinger of "Morgan Stanley" Upgraded from Hold to Buy and Held Target at $27 on, Monday, November 5th, 2018
  • Jami Rubin of "Goldman Sachs" Maintained at Strong Buy and Held Target at $30 on, Monday, October 1st, 2018